Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 469 (LINC00469)
- Target
- LINC00469
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Non-protein coding RNA, Other
01
Overview
Long intergenic non-protein coding RNA 469 (LINC00469) is a human gene transcribed as a non-coding RNA that does not overlap any protein-coding gene and belongs to the lincRNA subclass of long non-coding RNAs[1][6][7]. It localizes to chromosome 17 (chr17:73749270-73828537, minus strand)[1]. LINC00469 produces several transcript variants, all classified as lincRNAs[1]. While lincRNAs are known to play diverse roles in gene regulation, chromatin remodeling, RNA stability, and other cellular processes, the specific biological function of LINC00469 remains poorly characterized, and there is no literature linking it to disease, drug interaction, or use as a therapeutic target[1][4][7]. It is annotated in genomic databases but lacks experimental or clinical associations at this time[1][4][7].
- Other names
- C17orf54FLJ40319GC17M071746GC17M073750GC17M073856GC17M078957GC17M086124GC17M090267GC17M094209
02
Biological functions
Regulation of transcriptionChromatin remodelingRNA stabilityScaffolding molecular complexesFine-tuning gene expression with tissue specificity
03
Disease associations
CancerDevelopmental processesDisease progression
04
Safety considerations
No safety concerns or therapeutic challenges are reported for LINC00469 due to lack of evidence for drug interaction or clinical targeting
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 469 (LINC00469).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 469 (LINC00469).